Pharmacy

The FDA said Walgreens has addressed violations related to drug listing deficiencies for one of its products, according to a Dec. 19 close-out letter. The agency previously cited Walgreens in September 2023 for discrepancies in the electronic listing file of…

Mark Cuban, co-founder of Cost Plus Drugs Co., and Optum CEO Patrick Conway, MD, sparred over drug prices, pharmacy benefit managers and a range of other healthcare issues during a Dec. 16 conversation in Washington, D.C. hosted by Johns Hopkins…

Specialty medications, which can cost between $10,000 and upward of $5 million, now account for 52% of U.S. pharmaceutical sales, according to a Dec. 30 report from the Healthcare Distribution Alliance, which represents pharmaceutical distributors.  These therapies pose significant logistics…

Duarte, Calif.-based City of Hope and Eli Lilly have partnered on an oncology-based pharmacy residency program.  Wafa Samara, PharmD, vice president and chief pharmacy officer at City of Hope, shared news of the partnership in a Dec. 29 LinkedIn post. …

The number of active drug shortages has declined sharply since June, according to the FDA’s drug shortage database. Seventy-five drugs were in shortage as of Dec. 30, down from 194 in mid-June. The decline reflects updates to the FDA’s database,…

From payer shifts to regulatory milestones, GLP-1 therapies for obesity and diabetes continued to reshape the healthcare landscape in December. Here are six updates: 

In 2025, the FDA approved 73 first-time generic drugs.  Here are the generics and their indication, in order of approval date:  Note: The FDA’s information is current as of Dec. 18.  1. Phytonadione injection — For select coagulation disorders. 2.…

A federal judge granted a temporary restraining order blocking the Department of Health and Human Services from launching its 340B Rebate Model Pilot Program, which was scheduled to begin Jan. 1, 2026. U.S. District Judge Lance Walker of the District…

The FDA has accepted a biologics license application from Inovio for a potential treatment for adults with recurrent respiratory papillomatosis. Although the application was filed under the accelerated approval pathway, the FDA said in its acceptance letter that Inovio did…

As regulatory pressure mounts and workforce shortages persist, Louisville, Ky.-based Baptist Health System is positioning pharmacy as a safeguard for medication access and a driver of system growth. On an episode of the “Becker’s Pharmacy Leadership Podcast,” Nilesh Desai, chief…